24 May 2013
Keywords: Biogen Idec, Knopp, ALS, Lou Gehrig's disease, Licensing
Article | 19 August 2010
US biotech firm Biogen Idec has entered into an exclusive, worldwide license agreement with Knopp Neurosciences under which it will ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 August 2010
20 August 2010
© 2013 thepharmaletter.com